Hi RB, if we were to say that all performance targets are met,...

First 25 Last

Share
Profile

Follow
HairyRichard

1,851 Posts.

134

03/03/19

12:43

Post #: 37634840
Share

Originally posted by Red Baron: ↑

I think there's a bit of misinformation here.
As I posted earlier, the Appendix 3B issued after the AGM shows 103.2m shares on issue, NOT an extra 103.2m
The AGM authorised 10m to be issued for Rotogro Inc & Rotogro Tech as well as 16.65m for Supra.
So total 129.85m
These 10m + 16.65m shares have not been issued yet. I'd expect the 10m to be issued shortly & the 16.65 to be issued as milestones with the LD are met.
They will release another Appendix 3B when these shares are issued.

The performance shares are based on performance targets, some will be met some wont.
For example the 5m Class A Performance Rights expired last June & were not issued
Very unlikely the 7m Class B Performance Rights will be issued - need $20m in sales by June
These performance rights were issued 2 years ago with the IPO
The Hanson Performance shares approved at the AGM will probably get issued, the bulk of those would only be issued in 2023 - 5m total shares
The Rotogro Inc Performance shares approved at the AGM also require sales targets over the next 3 years to be progressively issued.

Any new expanding company is going to have capital requirements meaning dilution, many up & coming mining companies have billions of shares on issue. We have been lucky, most of the dilution we've had is for assets Supra, Hansons (GFS), the latter is already contributing to our bottom line.

Expand

Hi RB, if we were to say that all performance targets are met, the SOI should be around 220m, right?

That is if the Notice of AGM/Proxy form page 15 is anything to go by (Dated 30/1/19)

As you say, some targets wont be met, however I like to calculate assuming the worst, so I put all SOI into my market cap calcs.

RGI Price at posting: 26.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

CHW

Cleo adds Royal Women's Hospital to its clinical trial for ovarian cancer diagnosis

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

There are more pages in this discussion • 24 more messages in this thread...

First 25 Last

Add RGI (ASX) to my watchlist

Hi RB, if we were to say that all performance targets are met,...

Top Stories

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Cleo adds Royal Women's Hospital to its clinical trial for ovarian cancer diagnosis

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025